![](https://monteverdelaw.com/wp-content/uploads/case-logo/translate-bio-inc.png)
Translate Bio, Inc. (TBIO) relating to its proposed acquisition by Sanofi. Under the terms of the agreement, TBIO shareholders will receive $38.00 in cash per share.
Translate Bio, Inc. (TBIO) relating to its proposed acquisition by Sanofi. Under the terms of the agreement, TBIO shareholders will receive $38.00 in cash per share.